Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clinical experience with Dilatol therapy in EPH-gestoses].

K Müller

    Zentralblatt Fur Gynakologie
    |January 1, 1975
    PubMed
    Summary

    Dilatol effectively reduced blood pressure in patients with EPH-gestosis. However, long-term use may decrease effectiveness, necessitating careful monitoring and potential early delivery.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lichen metabolites. 1. Inhibitory action against leukotriene B4 biosynthesis by a non-redox mechanism.

    Journal of natural products·1999
    Same author

    Lichen metabolites. 2. Antiproliferative and cytotoxic activity of gyrophoric, usnic, and diffractaic acid on human keratinocyte growth.

    Journal of natural products·1999
    Same author

    Reconstitution of the actin-scavenger system after orthotopic liver transplantation for end-stage liver disease: a prospective and longitudinal study.

    Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·1999
    Same author

    Inhibition of keratinocyte growth by different Nepalese zanthoxylum species.

    Phytotherapy research : PTR·1999
    Same author

    Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major.

    Infection and immunity·1999
    Same author

    A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo.

    Bone·1999

    Area of Science:

    • Obstetrics and Gynecology
    • Pharmacology

    Context:

    • EPH-gestosis, characterized by hypertension, poses risks during pregnancy.
    • Managing hypertension in EPH-gestosis is crucial for maternal and fetal well-being.

    Purpose:

    • To evaluate the efficacy and safety of Dilatol (a beta-adrenergic substance) in treating hypertension in EPH-gestosis.
    • To assess the impact of Dilatol on blood pressure and pregnancy outcomes.

    Summary:

    • Dilatol treatment lowered systolic and diastolic blood pressure in 11 EPH-gestosis patients.
    • Therapeutic resistance increased with long-term Dilatol use.
    • Treatment requires close monitoring for timely intervention, including potential premature delivery.
    • No adverse effects were observed in mothers or infants within 4 weeks of treatment (up to 500 mg Dilatol).

    Impact:

    • Dilatol demonstrates potential for managing hypertension in EPH-gestosis.
    • The study highlights the importance of continuous patient monitoring and individualized treatment plans.
    • Further research is needed to confirm the impact of beta-adrenergic substances on perinatal mortality in severe EPH-gestosis.

    Related Experiment Videos